Background: The protective effects of off-pump (OPCAB) compared to conventional (CCAB) coronary artery bypass graft surgery on neurological injury and inflammation has been controversial. We evaluated pre-and postoperative levels of the brain injury marker, S100β, and markers of inflammation, Interleukin-6 (IL-6) and high sensitivity C-reactive protein (hs-CRP) in a prospective randomized controlled trial.
Methods:A sub-group sample of the randomized controlled trial of 50 consecutive randomized patients (n=27 CCAB, n=23 OPCAB) was utilized for the present biomarker analysis. Each patient had blood drawn before and after surgery. Analysis of variance and Kruskal-Wallis were used to assess significant differences in biomarkers.Results: There was no difference in post-procedure S100β (p=0.1) or change in S100β from baseline (p=0.9). Hs-CRP and IL-6 were higher in the OPCAB arm post-procedure (P CRP =0.001; P IL-6 =0.053) and change from baseline (P CRP =0.003; P IL-6 =0.001).
Conclusion:OPCAB did not result in preventing neurological injury over CCAB; however, OPCAB had significantly more inflammation than CCAB following the procedure.